Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy ; volume:21 ; number:1 ; day:26 ; month:9 ; year:2022 ; pages:1-19 ; date:12.2022
Molecular cancer ; 21, Heft 1 (26.9.2022), 1-19, 12.2022
- Urheber
-
Wu, Yuze
Yi, Ming
Niu, Mengke
Mei, Qi
Wu, Kongming
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-022-01657-y
- URN
-
urn:nbn:de:101:1-2022121421124564890587
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wu, Yuze
- Yi, Ming
- Niu, Mengke
- Mei, Qi
- Wu, Kongming
- SpringerLink (Online service)
Ähnliche Objekte (12)
Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
Correction to: Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
Interaction of mycobacteria with myeloid-derived suppressor cells
Myeloid-derived suppressor cells regulate B-cell responses
FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion
Phenotypic and functional dissection of myeloid-derived suppressor cells
Myeloid-derived suppressor cells in cryopyrin-associated periodic syndromes
Myeloid-derived suppressor cells in non-neoplastic inflamed organs
Regnase-1 downregulation promotes pancreatic cancer through myeloid-derived suppressor cell-mediated evasion of anticancer immunity
Characterization and Targeting of Myeloid-Derived Suppressor Cells in Acute Myeloid Leukemia
Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation
Myeloid-derived suppressor cells in hematological malignancies: friends or foes
Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
Correction to: Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
Interaction of mycobacteria with myeloid-derived suppressor cells
Myeloid-derived suppressor cells regulate B-cell responses
FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion
Phenotypic and functional dissection of myeloid-derived suppressor cells
Myeloid-derived suppressor cells in cryopyrin-associated periodic syndromes
Myeloid-derived suppressor cells in non-neoplastic inflamed organs
Regnase-1 downregulation promotes pancreatic cancer through myeloid-derived suppressor cell-mediated evasion of anticancer immunity
Characterization and Targeting of Myeloid-Derived Suppressor Cells in Acute Myeloid Leukemia
Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation
Myeloid-derived suppressor cells in hematological malignancies: friends or foes
Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
Correction to: Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
Interaction of mycobacteria with myeloid-derived suppressor cells
Myeloid-derived suppressor cells regulate B-cell responses
FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion
Phenotypic and functional dissection of myeloid-derived suppressor cells
Myeloid-derived suppressor cells in cryopyrin-associated periodic syndromes
Myeloid-derived suppressor cells in non-neoplastic inflamed organs
Regnase-1 downregulation promotes pancreatic cancer through myeloid-derived suppressor cell-mediated evasion of anticancer immunity
Characterization and Targeting of Myeloid-Derived Suppressor Cells in Acute Myeloid Leukemia
Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation